Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Equities decline as BSE Midcap and Smallcap plunge

    3,000 equities decline as BSE Midcap and Smallcap plunge up to 8%


    Finance Outlook India Team | Thursday, 21 March 2024

    Market observers are wary of larger markets, but analysts are optimistic about these themes. Amidst the current slump in broader markets, investors' wealth was lost by as many as 3,018 second-rung equities in March. The BSE Midcap index fell 4.03% over the same period that the BSE Smallcap index fell 8.27%. Conversely, the main equity index, the BSE Sensex, experienced a mere 0.55% decrease. For the foreseeable future, market observers are wary of the larger markets due to concerns over value.

    As many as 389 stocks have seen a decline of more than 20% so far in March. With a fall of 58.42%, Growington Ventures India was the biggest laggard. It was followed by Thinkink Picturez (down 50.91%) and Raghuvansh Agrofarms (down 50.61).

    Shree Precoated Steels, Genpharmasec, India Pesticides, IIFL Finance, Innokaiz India, Vaswani Industries, Duke Offshore, SGN Telecoms, Toyam Sports, Santosh Fine-Fab, and UH Zaveri also declined somewhere between 40% and 47% during the same period.

    Up to 389 equities have experienced a 20% or more loss thus far in March. Growington Ventures India fell by 58.42%, making it the largest laggard. It was followed by Raghuvansh Agrofarms (down 50.61) and Thinkink Picturez (down 50.91%).

    During the same time period, there was a 40%–47% fall in Shree Precoated Steels, Genpharmasec, India Pesticides, IIFL Finance, Innokaiz India, Vaswani Industries, Duke Offshore, SGN Telecoms, Toyam Sports, Santosh Fine-Fab, and UH Zaveri.

    Siddhartha Bhaiya, Managing Director and Chief Investment Officer of Aequitas Investments, expressed his opinions about the larger markets by saying, "Small- and mid-caps have gone through a golden four-year period since Covid-19." Large amounts of money have poured into the stock markets as a result of the governments' quantitative easing, to the point where banks have been having difficulty setting deposit rates. Throughout that period, the small- and mid-cap indices have increased 4-4.5, respectively. The markets are currently rife with excesses. We've witnessed a huge number of promoter sales and an abundance of initial public offerings, especially in the SME sector.



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25